Unlocking the potential of antibody–drug conjugates for cancer therapy
… We then propose a path forward by highlighting several hypotheses and novel strategies
to maximize the potential benefit that ADCs can provide to patients with cancer. …
to maximize the potential benefit that ADCs can provide to patients with cancer. …
Small-molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer
K McClinch, RA Avelar, D Callejas, S Izadmehr… - Cancer research, 2018 - AACR
… PP2A as a novel strategy for the treatment of prostate cancer. … were adjusted for multiple
hypotheses testing using the p.… been largely ignored for drug development because of their …
hypotheses testing using the p.… been largely ignored for drug development because of their …
A framework for the development of effective anti-metastatic agents
…, Cancer Research UK and Cancer … - Nature Reviews …, 2019 - nature.com
… To assist the cancer drug discovery and development … types of cancer, notably breast and
prostate cancer and melanoma 170 … These studies offer a provocative translational hypothesis, …
prostate cancer and melanoma 170 … These studies offer a provocative translational hypothesis, …
Accelerating anticancer drug development—opportunities and trade-offs
SJ Nass, ML Rothenberg, R Pentz, H Hricak… - Nature Reviews …, 2018 - nature.com
… , in the form of novel trial designs or modelling strategies, to … patients with metastatic
castration-resistant prostate cancer … secondary analyses to test prespecified hypotheses can …
castration-resistant prostate cancer … secondary analyses to test prespecified hypotheses can …
Treatment of advanced prostate cancer
MY Teo, DE Rathkopf, P Kantoff - Annual review of medicine, 2019 - annualreviews.org
… -resistant prostate cancer. We review clinical trials and survival benefit for these therapies
and assess how the understanding of the disease shifted as these therapies were developed. …
and assess how the understanding of the disease shifted as these therapies were developed. …
[HTML][HTML] Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
… The biological definition of oligometastatic prostate cancer is open to interpretation as is the
entire concept that this is a prognostic and therapeutically distinct subset of patients that falls …
entire concept that this is a prognostic and therapeutically distinct subset of patients that falls …
[HTML][HTML] Epidemiology of prostate cancer
P Rawla - World journal of oncology, 2019 - ncbi.nlm.nih.gov
… biological mechanism is described as “prostate stagnation hypothesis”, which involves the
prostatic … This information will provide an opportunity for the development of novel targeted …
prostatic … This information will provide an opportunity for the development of novel targeted …
Screening out irrelevant cell-based models of disease
… the discovery of many basic biological processes, they often fail to provide an adequate platform
for drug discovery … potential of novel lead compounds and new target hypotheses. ECM, …
for drug discovery … potential of novel lead compounds and new target hypotheses. ECM, …
Drug repurposing: a promising tool to accelerate the drug discovery process
… drug discovery because it provides a novel way to explore old … Hypothesis-driven strategies
for drug repurposing can … Metformin Type II diabetes Advanced prostate cancer Inhibition of …
for drug repurposing can … Metformin Type II diabetes Advanced prostate cancer Inhibition of …
TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells
… To test this hypothesis, we first compared the level of cGMP in … sGC may provide a novel
strategy to treat TMPRSS2-ERG-… calculated based on at least 3 biological repeats. Student’s t-…
strategy to treat TMPRSS2-ERG-… calculated based on at least 3 biological repeats. Student’s t-…